HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 43797,
"next": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=40640&ordering=-name",
"previous": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=40600&ordering=-name",
"results": [
{
"accession": "MS:1002587",
"name": "API 165",
"definition": "Applied Biosystems/MDS SCIEX API 165 MS.",
"term_type": "instrument"
},
{
"accession": "MS:1000144",
"name": "API 150EX Prep",
"definition": "Applied Biosystems/MDS SCIEX API 150EX Prep MS.",
"term_type": "instrument"
},
{
"accession": "MS:1000143",
"name": "API 150EX",
"definition": "Applied Biosystems/MDS SCIEX API 150EX MS.",
"term_type": "instrument"
},
{
"accession": "MS:1002586",
"name": "API 100LC",
"definition": "Applied Biosystems/MDS SCIEX API 100LC MS.",
"term_type": "instrument"
},
{
"accession": "MS:1002585",
"name": "API 100",
"definition": "Applied Biosystems/MDS SCIEX API 100 MS.",
"term_type": "instrument"
},
{
"accession": "MS:1000695",
"name": "apex ultra",
"definition": "Bruker Daltonics' apex ultra: ESI, MALDI, Nanospray, APCI, APPI, Qh-FT_ICR.",
"term_type": "instrument"
},
{
"accession": "MS:1000142",
"name": "apex Q",
"definition": "Bruker Daltonics' apex Q: ESI, MALDI, Nanospray, APCI, APPI, Qh-FT_ICR.",
"term_type": "instrument"
},
{
"accession": "MS:1000141",
"name": "apex IV",
"definition": "Bruker Daltonics' apex IV: ESI, MALDI, Nanospray, APCI, APPI, Qh-FT_ICR.",
"term_type": "instrument"
},
{
"accession": "CLO:0001547",
"name": "A.P. cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0001738",
"name": "AP95 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0001737",
"name": "A-P92 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0001735",
"name": "AP.6 cell",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "CLO:0001736",
"name": "AP-3 cell",
"definition": "['disease: hybridoma']",
"term_type": "cell line"
},
{
"accession": "CLO:0037364",
"name": "AP-1-bla ME-180",
"definition": "['ME-180 cells modified with a beta lactamase reporter under control of the activator protein-1 response element']",
"term_type": "cell line"
},
{
"accession": "NCBITaxon:57176",
"name": "Aotus vociferans",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "NCBITaxon:9504",
"name": "Aotus <primates>",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "NCBITaxon:37293",
"name": "Aotus nancymaae",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "NCBITaxon:30591",
"name": "Aotus azarai",
"definition": "[]",
"term_type": "cell line"
},
{
"accession": "EFO:0000266",
"name": "aortic valve stenosis",
"definition": "['A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.', 'Aortic valve stenosis is a aortic valve disease caused by the incomplete opening of the aortic valve. The aortic valve controls the direction of blood flow from the left ventricle to the aorta. When in good working order, the aortic valve does not impede the flow of blood between these two spaces. Under some circumstances, the aortic valve becomes narrower than normal, impeding the flow of blood. This is known as aortic valve stenosis, or aortic stenosis, often abbreviated AS.', 'Aortic valve stenosis is a aortic valve disease caused by the incomplete opening of the aortic valve. The aortic valve controls the direction of blood flow from the left ventricle to the aorta. When in good working order, the aortic valve does not impede the flow of blood between these two spaces. Under some circumstances, the aortic valve becomes narrower than normal, impeding the flow of blood. This is known as aortic valve stenosis, or aortic stenosis, often abbreviated as AS.']",
"term_type": "cell line"
},
{
"accession": "DOID:62",
"name": "aortic valve disease",
"definition": "[]",
"term_type": "cell line"
}
]
}